Arbutus Biopharma
ABUS
#6219
Rank
HK$6.56 B
Marketcap
HK$33.60
Share price
-3.60%
Change (1 day)
23.42%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): -HK$2.02

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2024 the company made an earnings per share (EPS) of -HK$2.98 an increase over its 2023 EPS that were of -HK$3.45.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.02-32.08%
2024-HK$2.98-13.64%
2023-HK$3.45-4.35%
2022-HK$3.60-44.58%
2021-HK$6.50-17%
2020-HK$7.83-65.4%
2019-HK$22.64138.84%
2018-HK$9.48-22.44%
2017-HK$12.22-78.45%
2016-HK$56.71424.64%
2015-HK$10.81-20.19%
2014-HK$13.5487.96%
2013-HK$7.21-142.59%
2012HK$16.92-342.7%
2011-HK$6.97-25.82%
2010-HK$9.4047.8%
2009-HK$6.36-43.55%
2008-HK$11.26158.91%
2007-HK$4.35-111.88%
2006HK$36.62-552.53%
2005-HK$8.09-71.77%
2004-HK$28.67-14.48%
2003-HK$33.52-8.95%
2002-HK$36.8270.07%
2001-HK$21.6548.01%
2000-HK$14.63-38.54%
1999-HK$23.80-24.6%
1998-HK$31.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-HK$0.47-76.92% Bahamas
NRC Health
NRC
HK$5.48-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA